Envoy Medical, Inc.
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Nov 18, 2026 (22 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 6, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Aug 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 27, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 33% |
| Jul 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 31, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| May 27, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9.5 | 37% |
| Apr 21, 2025 | Ascendiant Capital | maintain | Buy → Buy | $9.25 | 37% |
| Dec 6, 2024 | Ascendiant Capital | maintain | Buy → Buy | $9 | 37% |
| Oct 14, 2024 | Brookline Capital | initiate | — → Buy | $9 | 38% |
| Sep 3, 2024 | Ascendiant Capital | maintain | Buy → Buy | $8.75 | 37% |
| Jun 24, 2024 | Ascendiant Capital | initiate | — → Buy | $8.5 | 37% |
| Apr 3, 2024 | Lake Street | maintain | Buy → Buy | $6 | 47% |
| Dec 21, 2023 | Northland Capital Markets | initiate | — → Outperform | $0 | 50% |
| Nov 28, 2023 | Lake Street | initiate | — → Buy | $3 | 47% |
No cross-platform signals in the last 90 days